Acumen Pharmaceuticals (ABOS) Prepaid Assets (2020 - 2026)
Acumen Pharmaceuticals (ABOS) posted Prepaid Assets of $5.0 million for Q1 2026, down 12.85% sequentially from $5.7 million in Q4 2025, and down 13.78% YoY from $5.8 million in Q1 2025.
Acumen Pharmaceuticals (ABOS) Prepaid Assets (2020 - 2026) Analysis & Trends
Acumen Pharmaceuticals has reported Prepaid Assets for 7 years, with the latest figure at $5.0 million in Q1 2026.
- Quarterly Prepaid Assets fell 13.78% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (down 13.78% YoY) and the FY2025 annual result came in at $5.7 million, down 20.7% from the prior year.
- Prepaid Assets retreated to $5.0 million in Q1 2026 per ABOS's latest filing, from $5.7 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $7.2 million in Q4 2024 and troughed at $181000.0 in Q3 2023.
- A 5-year average of $3.2 million and a median of $3.6 million in 2023 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 1510.55% in 2023, down 92.35% in 2023.
- Over 5 years, Prepaid Assets stood at $237000.0 in 2022, then surged by 1510.55% to $3.8 million in 2023, then jumped by 89.55% to $7.2 million in 2024, then slipped by 20.7% to $5.7 million in 2025, then decreased by 12.85% to $5.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $5.0 million, $5.7 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Acumen Pharmaceuticals | 226.87 Mn | 226.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.58 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 5.74 Mn |
| Sep 30, 2025 | 5.54 Mn |
| Jun 30, 2025 | 5.04 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Dec 31, 2024 | 7.24 Mn |
| Sep 30, 2024 | 457,000.00 |
| Jun 30, 2024 | 405,000.00 |
| Mar 31, 2024 | 395,000.00 |
| Dec 31, 2023 | 3.82 Mn |
| Sep 30, 2023 | 181,000.00 |
| Jun 30, 2023 | 4.66 Mn |
| Mar 31, 2023 | 3.62 Mn |
| Dec 31, 2022 | 237,000.00 |
| Sep 30, 2022 | 2.37 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Dec 31, 2021 | 140,000.00 |
| Sep 30, 2021 | 4.84 Mn |